Your session is about to expire
← Back to Search
Ultrasound for Kidney Stones
N/A
Recruiting
Led By Thomas Chi, M.D.
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights
Study Summary
This trial is testing how well ultrasound works to find kidney stone fragments, compared to the current standard (fluoroscopy).
Eligible Conditions
- Kidney Stones
- Ultrasound Therapy Complications
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Diagnostic accuracy detecting residual fragments during retrograde intrarenal surgery
Secondary outcome measures
Negative predictive value detecting residual fragments during retrograde intrarenal surgery
Operative time in minutes
Positive predictive value detecting residual fragments during retrograde intrarenal surgery
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: UltrasoundExperimental Treatment1 Intervention
Before completing retrograde intrarenal surgery, a complete endoscopic examination will be performed along with ultrasound by the same endourologist to determine the size of the largest residual fragment.
Group II: FluoroscopyActive Control1 Intervention
Standard of care, control Before completing retrograde intrarenal surgery, a complete endoscopic examination will be performed along with fluoroscopy by the same endourologist to determine the size of the largest residual fragment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ultrasound
2013
Completed Phase 1
~1950
Find a Location
Who is running the clinical trial?
University of California, San FranciscoLead Sponsor
2,500 Previous Clinical Trials
15,236,299 Total Patients Enrolled
1 Trials studying Kidney Stones
3,299 Patients Enrolled for Kidney Stones
Thomas Chi, M.D.Principal InvestigatorUniversity of California, San Francisco
1 Previous Clinical Trials
100 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are pregnant.You have had a kidney transplant.Your kidney is not located in its normal position.You have severe pain that cannot be relieved when you arrive at the Emergency Department.
Research Study Groups:
This trial has the following groups:- Group 1: Ultrasound
- Group 2: Fluoroscopy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is recruitment currently active for this clinical experiment?
"The information hosted on clinicaltrials.gov suggests that this research endeavour is no longer actively recruiting participants. This investigation, which was initially advertised on the 11th of November in 2022, has not been updated since September 6th of the same year. Nevertheless, there are other 92 studies still searching for volunteers at present day."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger